- Storey RF et al. Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial. J Am Coll Cardiol 2016;67:1145-54.
- Montalescot G et al. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H (24) Analysis. JACC Cardiovasc Interv 2016;9:646-56.
- Bhatt DL et al. Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54. J Am Coll Cardiol 2016;67:2732-40.
- Sirker A et al. Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom. Eur Heart J 2016; 37 (16): 1312-20.
- Vaduganathan M et al. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy. J Am Coll Cardiol 2016;67:1661-71.
- Sibbing D et al. Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent? Eur Heart J 2016;37: 1284-95.
- Demaerschalk BM et al. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2016; 47:581-641.
- Chan KE et al. Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.J Am Coll Cardiol 2016;67:2888-99.
- Lopes RD et al. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Am J Med 2016;129:592-9.
- Larsen TB et al. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ 2016;353:i3189.
- Tereshchenko LG et al. Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis. J Am Heart Assoc 2016 May 20;5(5). pii: e003206.
- Kooistra HA et al. Risk of Bleeding and Thrombosis in Patients 70 Years Or Older Using Vitamin K Antagonists. JAMA Intern Med 2016 Jul 5 [Epub ahead of print].
